angiotensin ii has been researched along with Brain Hemorrhage, Cerebral in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Chen, W; Feng, H; Guo, C; Jia, Z; Li, C; Li, M; Liu, X; Shi, J; Tang, X; Wang, J; Xia, M; Yin, Y | 1 |
| Chen, WX; Feng, H; Ge, HF; Guo, C; Li, CC; Tang, XQ; Wang, B; Wang, J; Xia, M; Yin, Y | 1 |
| Csiszar, A; Lindsey, ML; Tarantini, S; Ungvari, Z; Yabluchanskiy, A | 1 |
| Ghasemnejad-Berenji, M; Khezri, MR | 1 |
| Ballabh, P; Conley, SM; Csiszar, A; Fulop, GA; Kiss, T; Martinez-Lemus, LA; Ramirez-Perez, FI; Tarantini, S; Toth, P; Ungvari, Z; Valcarcel Ares, MN; Yabluchanskiy, A | 1 |
| Ashpole, N; Csiszar, A; Fulop, GA; Gautam, T; Giles, CB; Sonntag, WE; Springo, Z; Tarantini, S; Ungvari, Z; Valcarcel-Ares, NM; Wren, JD; Yabluchanskiy, A | 1 |
| Chu, Y; Heistad, DD; Miller, JD; Rosenberg, GA; Wakisaka, Y | 1 |
| Chen, J; Chopp, M; Cui, X; Cui, Y; Liu, X; Lu, M; Roberts, C; Shehadah, A; Yan, T; Ye, X; Zacharek, A | 1 |
| Ergul, A; Fagan, SC; Hess, DC; Hohnadel, EJ; Pollock, DM | 1 |
| Pavan, E; Pessina, AC; Rossi, A; Rossi, G; Sacchetto, A | 1 |
| Näveri, L; Saavedra, JM; Strömberg, C | 1 |
| Badoer, E; McKinley, MJ; Oldfield, BJ | 1 |
| Nojima, K; Nomura, M; Saito, H; Tanaka, J; Yamamuro, Y | 1 |
| Mathai, ML; McKinley, MJ; Pennington, GL | 1 |
| Bowes, MP; Fagan, SC; Lyden, PD; Zivin, JA | 1 |
| Cameron, V; Donald, RA; Espiner, EA; MacFarlane, MR; Nicholls, MG | 1 |
| Agnoli, A; Battistini, N; Bozzao, L; Fieschi, C; Prencipe, M | 1 |
2 review(s) available for angiotensin ii and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Targets for vascular protection after acute ischemic stroke.
Topics: Acute Disease; Angiopoietins; Angiotensin II; Antioxidants; Apoptosis; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Arteries; Cerebral Hemorrhage; Chronic Disease; Endothelin-1; Endothelium, Vascular; Humans; Inflammation Mediators; Matrix Metalloproteinases; Neuroprotective Agents; Neutrophils; Oxidative Stress; Reactive Oxygen Species; Vascular Endothelial Growth Factor A; Vasculitis | 2004 |
Hypertensive cerebrovascular disease and the renin-angiotensin system.
Topics: Angiotensin II; Animals; Arteriosclerosis; Carotid Artery Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; Humans; Hypertension; Intracranial Embolism and Thrombosis; Renin-Angiotensin System | 1995 |
15 other study(ies) available for angiotensin ii and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Inhibition of plasma kallikrein mitigates experimental hypertension-enhanced cerebral hematoma expansion.
Topics: Angiotensin II; Animals; Blood Pressure; Cerebral Hemorrhage; Crotalid Venoms; Disease Models, Animal; Hypertension; Lectins, C-Type; Male; Mice; Plasma Kallikrein; Treatment Outcome | 2021 |
Iron chelation suppresses secondary bleeding after intracerebral hemorrhage in angiotensin II-infused mice.
Topics: Angiotensin II; Animals; Cerebral Hemorrhage; Deferoxamine; Drug Combinations; Hemoglobins; Hypertension; Intracranial Hemorrhages; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Male; Mice; Mice, Inbred C57BL; Microinjections; Muscle Contraction; Muscle, Smooth, Vascular; Neostriatum; Polyvinyls; Tantalum; Vasoconstrictor Agents | 2021 |
Effect of genetic depletion of MMP-9 on neurological manifestations of hypertension-induced intracerebral hemorrhages in aged mice.
Topics: Aging; Angiotensin II; Animals; Cerebral Hemorrhage; Hypertension; Matrix Metalloproteinase 9; Mice | 2021 |
Neurological effects of elevated levels of angiotensin II in COVID-19 patients.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin-Converting Enzyme 2; Blood-Brain Barrier; Cerebral Hemorrhage; COVID-19; Endocytosis; Humans; Permeability; Receptor, Angiotensin, Type 1; SARS-CoV-2 | 2021 |
IGF-1 Deficiency Promotes Pathological Remodeling of Cerebral Arteries: A Potential Mechanism Contributing to the Pathogenesis of Intracerebral Hemorrhages in Aging.
Topics: Aging; Angiotensin II; Animals; Cerebral Arteries; Cerebral Hemorrhage; Disease Models, Animal; Hypertension; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred C57BL | 2019 |
Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype.
Topics: Aging; Angiotensin II; Animals; Cerebral Hemorrhage; Disease Models, Animal; Extracellular Matrix; Gait; Hypertension; Infusion Pumps, Implantable; Insulin-Like Growth Factor I; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Oxidative Stress; Phenotype; Psychomotor Performance | 2017 |
Critical role for copper/zinc-superoxide dismutase in preventing spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice.
Topics: Angiotensin II; Animals; Blood Pressure; Brain; Cerebral Hemorrhage; Enzyme Activation; Humans; Hypertension; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidases; Oxidative Stress; Superoxide Dismutase; Superoxides | 2010 |
Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Blood-Brain Barrier; Cerebral Hemorrhage; Cerebrovascular Circulation; Cholesterol, HDL; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Niacin; Rats; Rats, Wistar; Vasodilator Agents | 2011 |
Angiotensin II AT2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Gas Analysis; Blood Pressure; Cerebral Cortex; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Hypotension; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Laser-Doppler Flowmetry; Losartan; Male; Pyridines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Tetrazoles; Vascular Resistance | 1994 |
Haemorrhage-induced production of Fos in neurons of the lamina terminalis: role of endogenous angiotensin II.
Topics: Angiotensin II; Animals; Captopril; Cerebral Hemorrhage; Cerebral Ventricles; Hypotension; Neurons; Oncogene Proteins v-fos; Paraventricular Hypothalamic Nucleus; Rats; Supraoptic Nucleus | 1993 |
Responses of subfornical organ neurons projecting to the hypothalamic paraventricular nucleus to hemorrhage.
Topics: Action Potentials; Angiotensin II; Animals; Cerebral Hemorrhage; Electric Stimulation; Evoked Potentials; Iontophoresis; Male; Micromanipulation; Neural Pathways; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Saralasin; Subfornical Organ | 1993 |
The effect of angiotensin AT1 receptor blockade in the brain on the maintenance of blood pressure during haemorrhage in sheep.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Arginine Vasopressin; Arteries; Blood Pressure; Brain; Cerebral Hemorrhage; Cerebrospinal Fluid; Dose-Response Relationship, Drug; Female; Injections, Intraventricular; Losartan; Renin; Sheep; Vasoconstrictor Agents | 1997 |
Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol.
Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Cerebral Hemorrhage; Cerebral Infarction; Hypertension; Intracranial Embolism and Thrombosis; Labetalol; Male; Rabbits | 1998 |
Stress hormones in blood and cerebrospinal fluid of conscious sheep: effect of hemorrhage.
Topics: Adrenocorticotropic Hormone; Angiotensin II; Animals; Arginine Vasopressin; Cerebral Hemorrhage; Consciousness; Epinephrine; Hormones; Norepinephrine; Sheep; Stress, Physiological | 1985 |
Derangement of regional cerebral blood flow and of its regulatory mechanisms in acute cerebrovascular lesions.
Topics: Acute Disease; Adult; Aged; Angiotensin II; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Cerebral Angiography; Cerebral Arteries; Cerebral Hemorrhage; Cerebrovascular Disorders; Dilatation; Electroencephalography; Humans; Hypercapnia; Hyperemia; Hypertension; Ischemic Attack, Transient; Middle Aged; Partial Pressure; Vasomotor System; Veins | 1968 |